Abstract: The presently disclosed subject matter provides a coating composition which allows for the co-delivery of two or more bioactive agents with independent control of loading level and release profile for each bioactive agent, an implantable medical device coated with the coating composition, and methods for preparing the coating composition.
Abstract: The use of long-chain alkenones to impart desired characteristics in personal care compositions for topical applications is described. The preparation of mixtures long-chain alkenones and synthetic derivatives thereof is presented. Examples of compositions include abrasive soaps, with alkenones serving as natural exfoliating agents. Alkenones and their derivatives can serve as emollients, occlusive agents, encapsulating agents, stabilizing agents, binding agents, thickening agents, surfactants, and antimicrobials.
Abstract: Described are probiotic compositions for human oral consumption comprising Veillonella bacteria. In some aspects, the probiotic compositions further comprise a salt of nitrate (NO3?) and/or a salt of nitrite (NO2?). In other aspects, the probiotic compositions further comprise a salt of nitrite (NO2?) and a natural source of nitrate. In certain embodiments, the probiotic compositions additionally comprises a polyphenol. Also described herein are methods of enhancing generation of bioactive nitrogen oxides in a human subject, of treating or preventing a gastrointestinal disorder in a human subject, of enhancing athletic performance in a human subject, and of enhancing administration of nitrite or nitrate in a human subject, wherein the human subject is administered the probiotic compositions described herein.
Abstract: Control or repellency of bed bugs is accomplished by bringing the bed bugs into contact with at least one of the compounds of the structure (I) Wherein R is selected from —OH, —OC(O)R4, —OR6, —(OR6)2, wherein each R6 is independently selected from an alkyl group containing from 1 to 4 carbon atoms and R4 is a branched or straight chain saturated or unsaturated hydrocarbyl group with zero to two double bonds and from 1 to 15 carbon atoms; X is O or CH2, with the proviso that when X is O, R can only be ?O; each Z is independently selected from (CH) and (CH2) y is a numeral selected from 1 and 2; R1 is selected from H or a branched or straight chain saturated or unsaturated hydrocarbyl group with zero to two double bonds and from 1 to 15 carbon atoms. R2 is selected from H and a branched or straight chain saturated or unsaturated hydrocarbyl group with zero to three double bonds and from 1 to 15 carbon atoms.
Abstract: The present disclosure relates to deodorant cosmetic compositions including calcium silicate and baking soda. Furthermore, the present disclosure relates to a cosmetic product containing such compositions and the use of the compositions or products for reduction of the body odor released by perspiration.
Abstract: The present invention relates to an effervescent tablet, which upon dissolution in water provides a solution useful as a mouth wash or oral rinse for the prevention or treatment of inflammatory processes of the soft tissues of the mouth, throat and oral cavity.
Abstract: Inorganic anions nitrate and nitrite influence metabolic rate and glucose homeostasis. Infusion of nitrite iv caused an acute drop in resting energy expenditure (oxygen consumption) and nitrate, when given perorally, caused a reduction in oxygen consumption during exercise and a depression of the increase in blood glucose observed after an oral glucose tolerance test. The doses of nitrate and nitrite did not cause any detectable change in methemoglobin levels of blood. Also, nitrate and nitrite did not alter lactate levels in blood. This discovery provides useful treatments to regulate the energy expenditure and glucose homeostasis of a mammal by administration of inorganic nitrite and/or nitrate.
Abstract: Composite materials that are palatable to a wood-destroying pest species and also pesticidal to the pest species can be used in pest control devices and can be used as wood substitutes for structural components, which are resistant to destruction by wood-destroying pests. The composite materials include a thermoplastic polymer, a food material for the pest and a pesticide. The composite material is formed by mixing a thermoplastic polymer, wood fragments or other cellulosic materials and a quantity of pesticide, and thereafter creating a molten material within a mixer, compounder, extruder or the like. The molten material is extruded or molded to form the desired shape.
Type:
Grant
Filed:
December 18, 2017
Date of Patent:
August 10, 2021
Assignee:
Dow AgroSciences LLC
Inventors:
Robert L. Hill, James E. King, Joseph J. DeMark, Anton Arnoldy, Mike P. Tolley, Donald E. Williams, III, Joseph E. Eger
Abstract: Medical use of natural and synthetic zeolites for treatment, prevention, and palliation in humans or animals of deleterious concentrations of ammonia, mercaptans, heavy metals and other toxins by oral administration.
Abstract: Use of a glucagon receptor antagonist in combination with a cholesterol absorption inhibitor for the treatment of diabetes and related conditions is disclosed.
Type:
Grant
Filed:
April 11, 2017
Date of Patent:
August 3, 2021
Assignee:
Merck Sharp & Dohme Corp.
Inventors:
Hong-Ping Guan, Jose M. Castro-Perez, Harry R. Davis, Samuel E. Engel, Douglas G. Johns, Songnian Lin, Stephen F. Previs, Thomas P. Roddy, Liangsu Wang, Sheng-Ping Wang, Yusheng Xiong
Abstract: A method of making a hair care formulation is provided, comprising: providing a hair care system concentrate, comprising: 9 to 15 wt % of a cellulose based cationic polymer; 39 to 60 wt % a polyalkylene glycol; 9 to 15 wt % a film forming nonionic polyethylene glycol polymer; 2.5 to 20 wt % a linear polypropylene glycol; and 10 to 35 wt % a polyethylene glycol diester of stearic acid; providing at least one hair care additive; providing water; adding the hair care system concentrate and the at least one hair care additive to the water to form the hair care formulation.
Type:
Grant
Filed:
June 29, 2017
Date of Patent:
July 27, 2021
Assignee:
Dow Brasil Sudeste Industrial LTDA
Inventors:
Maria Rita de Oliveira, Daisy de Fátima Scarparo de Sanctis, Mayra Penna
Abstract: The present invention relates to solid dosage forms of palbociclib comprising a water-soluble acid. The dosage forms described herein have desirable pharmacokinetic characteristics.
Type:
Grant
Filed:
May 24, 2016
Date of Patent:
July 20, 2021
Assignee:
Pfizer Inc.
Inventors:
Fady Makram Louiz Ibrahim, Matthew Patrick Mullarney, Ravi M. Shanker, Barbara Rodriguez Spong, Jian Wang
Abstract: A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition provides extended release of the API and has abuse deterrent features.
Type:
Grant
Filed:
January 27, 2017
Date of Patent:
July 20, 2021
Assignee:
SpecGX LLC
Inventors:
Brad L. Gower, Jae Han Park, Clifford J. Herman, Tsz Chung Lai, Kai Feng
Abstract: Disclosed is a hair care composition comprising cationic polymers and anionic particulates. The composition of the present invention provides improved deposition of anionic particulates.
Type:
Grant
Filed:
February 6, 2014
Date of Patent:
July 13, 2021
Assignee:
The Procter and Gamble Company
Inventors:
Kristine Suzanne So Yu, Mannie Lee Clapp
Abstract: An injectable, flowable composition, kits that include the same, and methods of medical treatment of a mammal (e.g., human) that include the administration of the same are provided.
Abstract: A method of making a modified hyaluronate composition including providing an aqueous solution of uncrosslinked hyaluronic acid or sodium hyaluronate in unbuffered 135 to 200 mM NaCl, crosslinking the uncrosslinked hyaluronic acid or sodium hyaluronate in the aqueous solution with a dialdehyde or disulfide crosslinking agent to provide crude modified hyaluronate having a soluble fraction and a crosslinked fraction with a 10% to 98% degree of crosslinking, centrifuging the crude modified hyaluronate and removing at least a portion of the soluble fraction, and optionally repeating the centrifuging and removing until the modified hyaluronate has less than 10% by weight of the soluble fraction based on the total weight of hyaluronate, with a soluble fraction polydispersity (Mw/Mn) of 1 to 1.6, an Rh of the crosslinked fraction of 150 nm to 2000 nm, and an Rz of the crosslinked fraction of 50 nm to 700 nm, wherein Rh>Rz.
Abstract: Emulsome compositions comprising phosphatidylcholine, cholesterol, tristearin, and one or more lipophilic bioactive agents such as vinpocetine are provided. The emulsomes may further comprise surface modifications of either [N-(carbonyl-methoxypropylethyleneglycol-2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine, sodium salt] (MPEG-DSPE) for peglyation or stearylamine for cationization. Methods of improving brain delivery of lipophilic bioactive agents by intranasally administering such emulsome compositions are also provided.
Type:
Grant
Filed:
November 25, 2020
Date of Patent:
July 13, 2021
Assignee:
King Abdulaziz University
Inventors:
Hibah M. Aldawsari, Shaimaa M. Badr-Eldin, Nourah Y. Assiri, Abdelsattar Omar
Abstract: A cosmetic composition for temporarily shaping hair includes, in a cosmetically acceptable support—respectively with respect to the total weight of the composition— e) from about 0.5% to about 8% by weight of a wax with a melting point of more than about 37° C., f) from about 0.5% to about 5% by weight of a fatty alcohol, g) from about 0.2% to about 2% by weight of a vinylpyrrolidone-containing polymer or copolymer, and h) from about 0.1% to about 10% by weight of composite powder comprising (A) powdered particles of a silicone elastomer, and (B) particles of silicon dioxide, wherein the particles of silicon dioxide (B) are immobilized on the surface of the powdered particles of the silicone elastomer (A).
Abstract: The present invention provides a 1,2,3-triazole derivative and an insecticide or acaricide containing the 1,2,3-triazole derivative as an active ingredient.
Abstract: The present invention relates to pharmaceutical antiretroviral compositions comprising a combination of antiretroviral agents (darunavir, dolutegravir and ritonavir), the manufacturing process thereof and use of the said compositions for the prevention, treatment or prophylaxis of HIV infection.